1) Objectives: Determination of the therapeutic efficacy of a combination of N-acetyl-cysteine (NAC) and cimetidine, in comparison with N-acetyl-cysteine alone, in acute acetaminophen toxicity.
2) Design: the present study is not belinded, randomized controlled trial.
3) The inclusion major criteria are: having para-clinical acetaminophen toxicity (toxic acetaminophen serum levels), and referring to the emergency poisoning department of Imam Reza Hospital, less than 8 hours from the poisoning.
Exclusion major criteria are as follows: having multiple toxicities; simultaneous diseases affecting the liver enzymes (e.g. heart failure, congenital liver defects, and hepatitis); recent (less than a week) or regular consumption of other drugs;Those patients who didn’t consent to the treatment, or were discharged from the hospital, were also excluded from the study.
4) Setting and conduct: among the patients admitted to the emergency department of Imam Reza Hospital, in the third quarter of 1392, those with suspected acetaminophen toxicity (according to the statements made by the patients, and their acquaintances, or the found evidence)were admitted to the hospital; if the clinical toxicity was approved, the patients were treated (based on the risk assessment nomogram of acetaminophen serum level), either with NAC or a combination of cimetidine injection + NAC .
5) interventions: N-acetyl-cysteine , a combination of N-acetyl-cysteine and cimetidine
6) main outcome: Serum acetaminophen levels, serum levels of aminotransferase